Pulse Biosciences (PLSE) Non-Current Debt (2021 - 2023)

Name: Pulse Biosciences (PLSE) Non-Current Debt (2021 - 2023) | Business Quant
Creator: Business Quant

Pulse Biosciences' quarterly Non-Current Debt came in at $65.0 million in Q1 2023, little changed quarter-over-quarter from $65.0 million in Q4 2022.

Pulse Biosciences has reported Non-Current Debt for 3 years, with the latest figure at $65.0 million in Q1 2023.

For the quarter ending Q1 2023, Non-Current Debt changed N/A year-over-year to $65.0 million; the trailing twelve-month figure through Mar 2023 stood at $65.0 million (changed N/A YoY), and the FY2022 full-year result was $65.0 million, changed N/A from the prior year.
Non-Current Debt for Q1 2023 stood at $65.0 million, roughly flat from $65.0 million in the prior quarter.
The five-year high for Non-Current Debt was $65.0 million in Q3 2022, with the low at $41.0 million in Q1 2021.
Average Non-Current Debt over 3 years is $59.0 million, with a median of $65.0 million recorded in 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	-
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	14.71 Bn
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	-
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	202.80 Mn
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	4.58 Bn
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	1.88 Bn
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	-
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	8.62 Bn
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	1.14 Bn
10	Pulse Biosciences	1.72 Bn	1.72 Bn	-	-

Download Data 🔒